Key points are not available for this paper at this time.
Three new POM-based compounds, with formulae Na0.63Ag3(Htba)2.37(tba)0.63(H2O)2(PMo12O40)·4H2O (Ag3PMo), Ag4(Htba)4(H2O)2(PMo12O40)(NO3)·H2O (Ag4PMo), and Ag3(Htba)2(tba)(PW12O40)0.5(NO3)0.5·13H2O (Ag3PW), were prepared with a 3-(4H-1,2,4-triazol-4-yl)benzoic acid (Htba) ligand, Keggin-type anions (PMo12O403–/PW12O403–), and a silver ion (Ag+). The structural features of these compounds are particularly different from the multinuclear subunits, which are Ag3(tba)3 clusters in Ag3PMo, Ag4(tba)3 chains in Ag4PMo, and Ag3(tba)32 clusters in Ag3PW, connected by multidonor atom tba ligands and Ag+ ions. Meanwhile, in these compounds, polyanions act as polydentate ligands to link adjacent Ag-tba metal–organic units and expand their spatial dimensions. These compounds, as heterogeneous catalysts, exhibit high stability and excellent catalytic activity to construct benzimidazoles. Ag3PMo could efficiently catalyze the condensation of benzene-1,2-diamines and benzaldehydes and produce benzimidazoles in good yields. In addition, Ag3PMo could be reused up to 7 times and was suitable for gram-scale reactions.
Liu et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: